Search Results - "NOONE, JOSHUA"

Incidence and Cost of Ankle Sprains in United States Emergency Departments by Shah, Shweta, Thomas, Abbey C., Noone, Joshua M., Blanchette, Christopher M., Wikstrom, Erik A.

“…Background: Ankle sprains represent a common injury in emergency departments, but little is known about common complications, procedures, and charges…”
Get full text

Higher healthcare cost and utilization before and after diagnosis of AATD in the United States by Blanchette, Christopher M, Whitmire, Sarah, Oh, Joshua, Noone, Joshua, Howden, Reuben, Ardiles, Thomas, Stone, Glenda A

“…Purpose Patients with alpha-1 antitrypsin deficiency (AATD) often experience substantial delays from the onset of symptoms to a diagnosis. We explored the…”
Get full text

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy by Bril, Vera, Blanchette, Christopher M, Noone, Joshua M, Runken, M. Chris, Gelinas, Deborah, Russell, James W

“…Abstract Purpose We reviewed the literature on chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetes mellitus (DM) and explored real-world data…”
Get full text

One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA by Arthur, Susan Tsivitse, Noone, Joshua M, Van Doren, Bryce A, Roy, Debosoree, Blanchette, Christopher M

“…Cachexia is a condition characterized as a loss in body mass or metabolic dysfunction and is associated with several prevalent chronic health conditions…”
Get full text

Cachexia among US cancer patients by Arthur, Susan T, Van Doren, Bryce A, Roy, Debosree, Noone, Joshua M, Zacherle, Emily, Blanchette, Christopher M

“…Cancer cachexia is a debilitating condition and results in poor prognosis. The purpose of this study was to assess hospitalization incidence, patient…”
Get more information

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S by Blanchette, Christopher M, Noone, Joshua M, Stone, Glenda, Zacherle, Emily, Patel, Ripsi P, Howden, Reuben, Mapel, Douglas

“…Non-cystic fibrosis bronchiectasis (NCFBE) is a rare, chronic lung disease characterized by bronchial inflammation and permanent airway dilation. Chronic…”
Get full text

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States by Runken, Michael C, Noone, Joshua M, Blanchette, Christopher M, Zacherle, Emily, Howden, Reuben

“…Primary immune-deficiency disease (PIDD) is a rare, debilitating disease of the immune system that predisposes the affected individual to infection, autoimmune…”
Get full text

Influence of acute and chronic streptozotocin-induced diabetes on the rat tendon extracellular matrix and mechanical properties by Volper, Brent D, Huynh, Richard T, Arthur, Kathryn A, Noone, Joshua, Gordon, Benjamin D, Zacherle, Emily W, Munoz, Eduardo, Sørensen, Mikkel A, Svensson, René B, Broderick, Tom L, Magnusson, S Peter, Howden, Reuben, Hale, Taben M, Carroll, Chad C

“…Diabetes is a major risk factor for tendinopathy, and tendon abnormalities are common in diabetic patients. The purpose of the present study was to evaluate…”
Get more information

Natural Progression of Alpha-1 Antitrypsin Deficiency Among Hospitalized COPD Patients in the US by Blanchette, Christopher, PhD, Noone, Joshua, PhD, Roy, Debosree, MS, Van Doren, Bryce, MPA, Zacherle, Emily, BS, Runken, Michael, Howden, Reuben, PhD

Get full text

Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US by Guptill, Jeffrey T, Runken, M Chris, Eaddy, Michael, Lunacsek, Orsolya E, Fuldeore, Rupali M, Blanchette, Christopher M, Zacherle, Emily, Noone, Joshua M

“…For chronic inflammatory demyelinating polyneuropathy (CIDP) patients, each branded intravenous immunoglobulin (IVIG) treatment differs in production…”
Get full text

Cachexia & debility diagnoses in hospitalized children and adolescents with complex chronic conditions: evidence from the Kids' Inpatient Database by Van Doren, Bryce A, Roy, Debosree, Noone, Joshua M, Blanchette, Christopher M, Arthur, Susan T

“…To characterize the frequency, cost, and hospital-reported outcomes of cachexia and debility in children and adolescents with complex chronic conditions…”
Get full text

One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States by Blanchette, Christopher M., Zacherle, Emily, Noone, Joshua M., Van Doren, Bryce A., Roy, Debosree, Howden, Reuben

“…Objectives: Little is known about severe chronic obstructive pulmonary disease (COPD) exacerbations among patients with Alpha-1 Antitrypsin Deficiency (AATD)…”
Get full text

Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function by Blanchette, Christopher M, Nunes, Anthony P, Lin, Nancy D, Mortimer, Kathleen M, Noone, Joshua, Tangirala, Krishna, Johnston, Stephen, Gutierrez, Benjamin

“…Risk evaluation and mitigation strategies (REMS), as mandated by the US Food and Drug Administration (FDA) for medications with the potential for harm, are…”
Get full text

Mental Health and Substance Misuse-Related Emergency Department Discharges in Urban Counties of North Carolina by Van Doren, Bryce A, Grimsley, Kathryn G, Noone, Joshua M, Neese, Jane B

“…National evidence suggests that there is considerable variation between regions in emergency department utilization for routine health care needs. Many…”
Get full text

The Impact of Immunodeficiency on Patients Receiving Immunologic-Based Multiple Sclerosis Therapies by Runken, Michael, Harville, Terry, Noone, Joshua

Get full text

Impact of Immunodeficiency on Multiple Sclerosis Patients Receiving Rituximab by Harville, Terry, Runken, Michael, Noone, Joshua

Get full text

766-P: Long-Term Effectiveness Associated with Maintenance Doses of Once-Weekly Semaglutide in U.S. Adults with Poorly Controlled Type 2 Diabetes by Tan, Xi, Cao, Yiwen, Dunn, Tyler J, Liang, Yuanjie, Noone, Joshua, Gamble, Cory L, King, Aaron A

“…Introduction & Objective: To evaluate long-term effectiveness associated with maintenance doses of once-weekly semaglutide (sema) in US adults with poorly…”
Get full text

774-P: Impact of Newer GLP-1 RAs on HbA1c in U.S. Adults with Type 2 Diabetes-A Population-Level Time-Series Analysis by Lv, Lei, Wang, Yan, Xie, Lin, Noone, Joshua, Alvarez, Sara B, Zhang, Yuehan, Song, Yan, Rotroff, Daniel M

“…Introduction & Objective: It is unclear whether glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatments improve population-level diabetes-related…”
Get full text

740-P: Persistence and Adherence of Once-Weekly GLP-1 Receptor Agonists in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease in a Real-World Setting by Dunn, Tyler, Zhu, Yong, Gronroos, Noelle, Xie, Lin, Noone, Joshua, Sargent, Andrew, Yedigarova, Larisa, Billings, Liana K

“…Introduction & Objective: Multiple clinical trials have shown cardiovascular benefits from glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in patients…”
Get full text

791-P: Comparing the Real-World Effects of Once-Weekly GLP-1 RAs and DPP-4 Inhibitors on Ischemic Stroke and Myocardial Infarction in Individuals with T2D and ASCVD by TAN, XI, LIANG, YUANJIE, RAJPURA, JIGAR R., YEDIGAROVA, LARISA, NOONE, JOSHUA, XIE, LIN, DE HAVENON, ADAM

“…Despite guidelines advocating for their use, there is limited real-world evidence comparing the effects of once-weekly (OW) glucagon-like peptide-1 receptor…”
Get full text